BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8013950)

  • 1. Chronic myelogenous leukemia: molecular diagnostic considerations.
    McClure JS; Litz CE
    Hum Pathol; 1994 Jun; 25(6):594-7. PubMed ID: 8013950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
    Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
    Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
    Mills KI; Stewart J; Burnett AK
    Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ; Phillips CN; Winton EF; Farhi DC
    Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
    Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
    Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular pathology of chronic myelogenous leukaemia.
    Kurzrock R; Talpaz M
    Br J Haematol; 1991 Oct; 79 Suppl 1():34-7. PubMed ID: 1931706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.
    Zaccaria A; Tassinari A; Guerrasio A; Rosso C; Lo Coco F; Diverio D; Testoni N; Celso B; Buzzi M; Tura S
    Haematologica; 1991; 76(3):183-7. PubMed ID: 1660437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Hooberman AL; Carrino JJ; Leibowitz D; Rowley JD; Le Beau MM; Arlin ZA; Westbrook CA
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4259-63. PubMed ID: 2498881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of chronic myelogenous leukaemia.
    Ankathil R; Nair MK
    Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
    Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia].
    Michalová K; Zemanová Z; Haskovec C; Rypácková B; Brdicka R
    Cas Lek Cesk; 1992 Dec; 131(24-25):729-32. PubMed ID: 1288873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structurally abnormal breakpoint cluster region gene in a transcription factor, hLH-2-negative human leukemia cell line.
    Wu HK
    Cancer Lett; 1995 Jun; 92(2):215-22. PubMed ID: 7600533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
    Kamada N; Tanaka K; Asou H
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of BCR-ABL rearrangement in chronic myeloid leukemia.
    Colleoni GW; Costa FF; Grignolli CR; Silva RS; Chauffaille ML; Kerbauy J; Saad ST
    Braz J Med Biol Res; 1996 Oct; 29(10):1307-10. PubMed ID: 9181101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias.
    Dhingra K; Talpaz M; Riggs MG; Eastman PS; Zipf T; Ku S; Kurzrock R
    Blood; 1991 Jan; 77(2):238-42. PubMed ID: 1985690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.